[Early postoperative mitomycin C instillation: when and how?].
The rationale for intravesical chemotherapy in the treatment of superficial bladder tumours is based on the knowledge of their natural history, particularly the propensity of a majority of tumours to relapses, while only a small proportion of these tumours present a risk of progression. The objective of intravesical chemotherapy is to prevent tumour implantation on the site of resection and to eliminate any residual disease responsible for recurrences; this treatment therefore constitutes "chemoprophylaxis". The objective of this technical note is to recall the practical modalities of early postoperative mitomycin C instillation with particular emphasis on two technical points.
Traxer
Olivier
O
Service d'Urologie, Hôpital Tenon, Paris, France. olivier.traxer@tnn.ap-hop-paris.fr
Gattegno
Bernard
B
D000283:Administration, Intravesical; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D004867:Equipment Design; D006801:Humans; D016685:Mitomycin / Q000008:administration & dosage*; D011182:Postoperative Care; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000601:surgery
D000903:Antibiotics, Antineoplastic; D016685:Mitomycin